In vitro release profiles of clonidine transdermal therapeutic systems and scopolamine transdermal patches.
Shah
V P
VP
Division of Biopharmaceutics, Food and Drug Administration, Rockville, Maryland 20857.
Tymes
N W
NW
Skelly
J P
JP
D000279:Administration, Cutaneous; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D003000:Clonidine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D012601:Scopolamine / Q000032:analysis; D012995:Solubility; D013997:Time Factors
D012601:Scopolamine; D003000:Clonidine